San Antonio

molecule
Biotech

MacroGenics' margetuximab nets OS gain in advanced breast cancer

MacroGenics presented new, phase 3 breast cancer data from its HER2-targeting antibody margetuximab as it works to finalize its BLA.
Conor Hale Dec 11, 2019 10:00am
San Antonio Texas USA downtown skyline

AstraZeneca, Daiichi's ADC keeps breast cancer at bay

Dec 11, 2019 8:00am
test tubes

Myriad study shows cancer test can predict therapy responses

Dec 7, 2018 8:30am